跳至主要内容
临床试验/NCT00089323
NCT00089323已完成不适用

Bone Marrow Analysis In Early-Stage Breast Cancer

NSABP Foundation Inc106 个研究点 分布在 2 个国家目标入组 1,630 人开始时间: 2007年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,630
试验地点
106
主要终点
Overall survival

研究概览

简要总结

RATIONALE: Diagnostic procedures that detect tumor cells in the bone marrow may help doctors predict disease recurrence and plan more effective treatment.

PURPOSE: This clinical trial is studying how well diagnostic procedures work in detecting tumor cells in the bone marrow of patients who have undergone surgery for stage I, stage II, or stage IIIA breast cancer.

详细描述

OBJECTIVES:

Primary

  • Determine the relative risk of death associated with the presence of tumor cells in the bone marrow of patients with stage I, II, or IIIA breast cancer undergoing surgery and bone marrow analysis using multicolor fluorescence immunocytochemistry and bright field immunocytochemistry.

Secondary

  • Compare multicolor fluorescence immunocytochemistry vs bright field immunocytochemistry in the detection of bone marrow micrometastases in these patients.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Overall survival

时间窗: From time of randomization to death from any cause through 10 years.

次要结局

  • Tumor cell presence as measured by bright-field and multicolor fluorescence immunocytochemical methods(As detected at time of analysis.)

研究者

申办方类型
Network
责任方
Sponsor

研究点 (106)

Loading locations...

相似试验

Diagnostic Procedures in Detecting Tumor Cells in... | 临床试验